T1	Participants 628 984	The Ventricular Tachycardia Ablation in Coronary Heart Disease (VTACH) study was a prospective, open, randomised controlled trial, undertaken in 16 centres in four European countries. Patients aged 18-80 years were eligible for enrolment if they had stable VT, previous myocardial infarction, and reduced left-ventricular ejection fraction (LVEF; <or=50%).
T2	Participants 985 997	110 patients
T3	Participants 1521 1614	107 patients were included in the ITT population (ablation group, n=52; control group, n=55).
